Reasons to Retain Fresenius Medical Stock in Your Portfolio for the Time Being
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 23 2025
0mins
Source: NASDAQ.COM
Company Overview: Fresenius Medical Care AG & Co. (FMS) is a leading provider of dialysis products and services, with a market cap of $15.11 billion and a strong global presence, having expanded through strategic acquisitions and partnerships.
Financial Performance: FMS shares have increased by 13.3% year-to-date, outperforming the industry, with earnings expected to grow by 12.6% over the next five years, despite facing challenges from rising costs and labor market issues.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like NVST with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on NVST
Wall Street analysts forecast NVST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVST is 22.22 USD with a low forecast of 18.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
5 Buy
7 Hold
1 Sell
Moderate Buy
Current: 24.080
Low
18.00
Averages
22.22
High
27.00
Current: 24.080
Low
18.00
Averages
22.22
High
27.00
About NVST
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
10 Small-Cap Stocks Set to Surge in 2026
- Small-Cap Stocks Performance: Small-cap stocks have started 2026 with strong momentum, indicating a positive trend in the market.
- Market Potential: Many of these companies are positioned to outperform the market, suggesting that the rally could continue.
Continue Reading
Envista to Report Q4 2025 Financial Results on February 5, 2026
- Earnings Release Schedule: Envista Holdings will report its Q4 2025 financial results on February 5, 2026, and will hold a conference call at 2:00 PM PT on the same day, lasting approximately one hour to provide detailed insights into its financial performance.
- Webcast and Replay: The conference call and accompanying slide presentation will be webcast on the 'Investors' section of Envista's website, with a replay available shortly after the conclusion and accessible for one year, ensuring investors can obtain information at their convenience.
- Dial-in Participation: Investors can participate by dialing 1-800-836-8184 within the U.S. or 1-646-357-8785 internationally a few minutes before the call starts, referencing Conference ID #54406, to engage in this important financial discussion.
- Company Background: Envista Holdings is a global leader in the dental industry, uniting over 30 trusted brands and committed to improving patients' lives through innovative technologies and services, showcasing its significant impact in modern dentistry.
Continue Reading